MARTIN , Jean-Charles

Prophylaxis by "KI 65 mg, breakable tablet" is a pharmacological countermeasure of radiological protection adapted for the prevention of thyroid cancer after exposure to radioactive iodine. A first modification of the marketing authorization of "KI 65 mg, breakable tablet" for repeated prophylaxis for adults and children above 12 years old was...

Single dose of potassium iodide (KI) is recommended to prevent the risk of thyroid cancer during nuclear accidents. However in the case of repeated/protracted radioiodine release, a unique dose of KI may not protect efficiently the thyroid against the risk of further developing a radiation-induced cancer. The new WHO guidelines for the use in...